Application of unsedated transnasal esophagogastroduodenoscopy in the diagnosis of hypopharyngeal cancer

Head Neck. 2009 Feb;31(2):153-7. doi: 10.1002/hed.20928.

Abstract

Background: This study evaluates the efficacy of unsedated transnasal esophagogastroduodenoscopy (EGD) in the diagnosis of hypopharyngeal cancer and screening of esophageal lesions.

Methods: Twenty-seven patients with newly diagnosed hypopharyngeal cancer were evaluated by transnasal EGD without conscious sedation.

Results: Twenty-two hypopharyngeal cancers arose from the pyriform sinus, and the other 5 tumors were from the posterior hypopharyngeal wall. Seventeen tumors were classified as T3-T4. Twenty-four hypopharyngeal tumors were pathologically proved malignancy by this technique. Regarding simultaneous esophageal lesions, esophageal dysplasia was noted in 4 patients and esophageal cancer occurred in 6 patients. The procedures were performed without difficulty except in 1 patient with huge posterior wall tumor. The mean procedure time was 22 minutes. All patients tolerated the procedure well, without significant bleeding or respiratory distress during examination.

Conclusion: Unsedated transnasal EGD is a safe, tolerable, and accurate endoscopic technique for diagnosis of hypopharyngeal cancer and screening of simultaneous esophageal cancer.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anesthesia, Local*
  • Carcinoma, Squamous Cell / diagnosis*
  • Carcinoma, Squamous Cell / therapy
  • Conscious Sedation*
  • Endoscopy, Digestive System / methods*
  • Esophageal Neoplasms / diagnosis
  • Female
  • Humans
  • Hypopharyngeal Neoplasms / diagnosis*
  • Hypopharyngeal Neoplasms / therapy
  • Male
  • Middle Aged
  • Nasal Cavity
  • Neoplasms, Multiple Primary / diagnosis
  • Prospective Studies